Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Authors Task Force Members, Lars Rydén, Peter J. Grant, et al.
European Heart Journal (2013) Vol. 34, Iss. 39, pp. 3035-3087
Open Access | Times Cited: 1861

Showing 1-25 of 1861 citing articles:

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker, et al.
European Heart Journal (2016) Vol. 37, Iss. 27, pp. 2129-2200
Open Access | Times Cited: 19131
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, et al.
European Heart Journal (2013) Vol. 34, Iss. 28, pp. 2159-2219
Open Access | Times Cited: 13716
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Joep Perk, Guy De Backer, H. Gohlke, et al.
European Heart Journal (2012) Vol. 33, Iss. 13, pp. 1635-1701
Open Access | Times Cited: 8464
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Marco Roffi, Carlo Patrono, Jean‐Philippe Collet, et al.
European Heart Journal (2015) Vol. 37, Iss. 3, pp. 267-315
Open Access | Times Cited: 7922
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo Piepoli, Arno W. Hoes, Stefan Agewall, et al.
European Heart Journal (2016) Vol. 37, Iss. 29, pp. 2315-2381
Open Access | Times Cited: 5947
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker, et al.
European Journal of Heart Failure (2016) Vol. 18, Iss. 8, pp. 891-975
Open Access | Times Cited: 5540
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4190
2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker, Philippe Kolh, Fernándo Alfonso, et al.
European Heart Journal (2014) Vol. 35, Iss. 37, pp. 2541-2619
Open Access | Times Cited: 4154
2014 ESC/EACTS Guidelines on myocardial revascularization
Philippe Kolh, Stephan Windecker, Fernándo Alfonso, et al.
European Journal of Cardio-Thoracic Surgery (2014) Vol. 46, Iss. 4, pp. 517-592
Open Access | Times Cited: 4094
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino, Peter J Grant, Victor Aboyans, et al.
European Heart Journal (2019) Vol. 41, Iss. 2, pp. 255-323
Open Access | Times Cited: 4088
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Jean‐Baptiste Ricco, Marie-Louise Bartelink, Martin Björck, et al.
European Heart Journal (2017) Vol. 39, Iss. 9, pp. 763-816
Open Access | Times Cited: 2870
Type 2 diabetes
Sudesna Chatterjee, Kamlesh Khunti, Melanie J. Davies
The Lancet (2017) Vol. 389, Iss. 10085, pp. 2239-2251
Closed Access | Times Cited: 2066
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
Authors Task Force Members, Steen Dalby Kristensen, Juhani Knuuti, et al.
European Heart Journal (2014) Vol. 35, Iss. 35, pp. 2383-2431
Open Access | Times Cited: 1548
Diabetic Cardiomyopathy
Guanghong Jia, Michael A. Hill, James R. Sowers
Circulation Research (2018) Vol. 122, Iss. 4, pp. 624-638
Open Access | Times Cited: 1319
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
Antonio Pelliccia, Sanjay Sharma, Sabiha Gati, et al.
European Heart Journal (2020) Vol. 42, Iss. 1, pp. 17-96
Open Access | Times Cited: 1263
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo Piepoli, Arno W. Hoes, Stefan Agewall, et al.
European Journal of Preventive Cardiology (2016) Vol. 23, Iss. 11, pp. NP1-NP96
Open Access | Times Cited: 1148
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
Anoop D Shah, Claudia Langenberg, Eleni Rapsomaniki, et al.
The Lancet Diabetes & Endocrinology (2014) Vol. 3, Iss. 2, pp. 105-113
Open Access | Times Cited: 1081
Clinical Update: Cardiovascular Disease in Diabetes Mellitus
Cecilia C. Low Wang, Connie N. Hess, William R. Hiatt, et al.
Circulation (2016) Vol. 133, Iss. 24, pp. 2459-2502
Open Access | Times Cited: 942
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
Kornelia Kotseva, David Wood, Dirk De Bacquer, et al.
European Journal of Preventive Cardiology (2015) Vol. 23, Iss. 6, pp. 636-648
Open Access | Times Cited: 936
Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis
Yuli Huang, Xiaoyan Cai, Weiyi Mai, et al.
BMJ (2016), pp. i5953-i5953
Open Access | Times Cited: 880
Chronic kidney disease
Kamyar Kalantar‐Zadeh, Tazeen H. Jafar, Dorothea Nitsch, et al.
The Lancet (2021) Vol. 398, Iss. 10302, pp. 786-802
Open Access | Times Cited: 864
CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
Ele Ferrannini, Michael Mark, Eric Mayoux
Diabetes Care (2016) Vol. 39, Iss. 7, pp. 1108-1114
Closed Access | Times Cited: 863
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Iciar Martín-Timón, Cristina Sevillano-Collantes, Amparo Segura-Galindo, et al.
World Journal of Diabetes (2014) Vol. 5, Iss. 4, pp. 444-444
Open Access | Times Cited: 860
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial
David Fitchett, Bernard Zinman, Christoph Wanner, et al.
European Heart Journal (2016) Vol. 37, Iss. 19, pp. 1526-1534
Open Access | Times Cited: 855
Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Victor Aboyans, Jean‐Baptiste Ricco, Marie-Louise E.L. Bartelink, et al.
European Journal of Vascular and Endovascular Surgery (2017) Vol. 55, Iss. 3, pp. 305-368
Open Access | Times Cited: 846
Page 1 - Next Page

Scroll to top